Generic Manufacturers Should Be Liable For Inadequate Label Warnings, Government Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Solicitor General advises the Supreme Court not to take up a case involving failure-to-warn claims for the heartburn drug Reglan.